Foxo SPAC Presentation Deck
KEY HIGHLIGHTS
Investment thesis
Multiple avenues for
value creation
COVID is driving life insurance sales,
agents seeking new products with a
smoother, simpler sales journey, and
boom in health, wellness, and longevity
FOXO INVESTOR DECK 2022 Page 6
Launching with scalable
infrastructure
E
Built on a best-in-class technology
platform with infrastructure capable
of supporting scaled growth in a large
and global industry
O
Next-Gen Life Insurance
Platform to modernize industry with saliva-
based epigenetic underwriting technology
that eliminates blood and urine requirements,
and embed longevity science as new value
proposition for consumers
Proprietary science and
technology
Proprietary and first-mover advantage
in applying saliva-based epigenetic
biomarker technology to underwriting,
not easily reproduced or copied
World class science
and management
Science confirmed by experts, value
propositions rigorously validated, and
prior management success in financial
product creation and distributionView entire presentation